In 2007, Pfizer US-PFE filed a lawsuit against Beijing Jialin Pharmaceutical Co., LTD. to Beijing No.1 Intermediate People's Court for patent infringement. Jialin then filed a request for
Oct 11 (Reuters) - Pfizer (PFE.N) has agreed to pay $50 million to settle claims by drug wholesalers that they overpaid for EpiPen allergy treatment devices as a result of anticompetitive tactics by
Feb 14 (Reuters) - Pfizer (PFE.N), has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay
April 29 (Reuters) - Pfizer (PFE.N) has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with rival Teva (TEVA.TA) to delay launching a less expensive generic
Covid-19 vaccine collaborators Pfizer and BioNTech are attempting to invalidate two patents owned by their rival Moderna that they were accused of infringing last year. In petitions to the US Patent
belonging to Pfizer (PFE.N) subsidiary Wyeth. U.S. District Judge Matthew Kennelly determined that the two patents Pfizer accused AstraZeneca of infringing with its blockbuster lung-cancer drug Tagrisso
LONDON, Sept 25 (Reuters) - Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the
BioNTech and Pfizer must pay damages to Moderna for the use of one of its patents in Germany. This was the ruling handed down today by Düsseldorf Regional Court in the dispute over mRNA vaccines. It
March 5 - Pfizer (PFE.N) and BioNTech (22UAy.DE) won a round in their legal battle with Moderna (MRNA.O) over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two
total 1 pages, 9 items